Medibact GuidesShop at Medibact

Stacking Module

GHRP-6 Stacking Module

GHRP-6 is the secretagogue defined by a side effect: a pronounced reported appetite drive. Whether that is a feature or a problem determines whether it belongs in a given stack at all, and it is the main reason it is chosen over or rejected in favour of Ipamorelin.

GHRP-6 Guide at MedibactGHRP-6 calculatorPeptide Stacking Guide

Educational use only — not medical advice. This page summarizes information reported in published research and community practice for educational purposes. It is not medical advice and not a recommendation to use any compound. Any doses, schedules, or combinations shown are examples of what has been reported, not instructions for you. Many peptides described here are research compounds that are not FDA-approved for the uses discussed and may be investigational or restricted. Effects, risks, and legal status vary; individual needs and results vary. Consult a qualified, licensed healthcare professional before making any decision. Do not use this content to diagnose, treat, or dose yourself.

How to think about stacking GHRP-6

  • GHRP-6 acts at GHS-R1a. Its complementary partner is a GHRH analog, not another secretagogue.
  • Its marked reported appetite stimulation is the practical differentiator. In a fat-loss-oriented stack it works directly against the objective; in a mass-oriented one it is sometimes the reason it is selected.
  • Like GHRP-2 it is reported to be less selective than Ipamorelin, with cortisol and prolactin effects attributed to it.
  • No controlled trial has studied GHRP-6 combined with anything.

Combinations in detail

GH Pulse Stack

GHRP-6 + CJC-1295 or Mod GRF 1-29
Why it is proposed
The classic secretagogue-plus-GHRH-analog construction, acting on two distinct receptors.
What is reported in practice
Reported drawn together, fasted, commonly at bedtime.
Cautions specific to this combination
The appetite effect is reported as substantial and is the usual reason this pairing is abandoned in favour of an Ipamorelin version.

Appetite & Recovery Stack

GHRP-6 + Ipamorelin
Why it is proposed
Sometimes reported as combining GHRP-6's appetite drive with Ipamorelin's selectivity.
What is reported in practice
Reported together in mass-oriented discussion.
Cautions specific to this combination
This is a class collision — both act at GHS-R1a, so it is redundant on mechanism. If the appetite effect is the actual goal, that is a different objective than adding GH signaling, and it should be reasoned about as such.

Healing Add-on

GHRP-6 + BPC-157 + TB-500
Why it is proposed
GH-axis support alongside the local repair pairing — genuinely different mechanisms.
What is reported in practice
Separate vials on separate schedules.
Cautions specific to this combination
Three scales to track. No combination data.

What to avoid, and why

  • Pairing two ghrelin-receptor secretagogues (Ipamorelin, GHRP-2, GHRP-6, Hexarelin) is the same redundancy on the other pathway — same receptor, same downstream pulse. The coherent construction takes one GHRH analog and one secretagogue, not two of either.
  • Using GHRP-6 in a fat-loss-oriented stack, where its reported appetite drive works directly against the objective.
  • Pairing GHRP-6 with Ipamorelin or GHRP-2 and expecting additive GH release — same receptor.

Related reading

The Peptide Stacking GuideAll stacking pages

Every combination described here is reported practice or mechanism-level reasoning. No controlled trial has studied any of these combinations, and nothing on this page is a personal protocol, a dose recommendation, or medical advice.